Editorial on a Phase I Study on Combined Modality Therapy in Esophageal Cancer

2004 ◽  
Vol 22 (5) ◽  
pp. 813-814
Author(s):  
David Ilson
1997 ◽  
Vol 7 (3) ◽  
pp. 15-23 ◽  
Author(s):  
Charles D. Blanke ◽  
Hak Choy ◽  
Steven D. Leach

Author(s):  
R.C. Miller ◽  
P.J. Atherton ◽  
B. Kabat ◽  
M. Fredericksen ◽  
C. Deschamps ◽  
...  

2003 ◽  
Vol 21 (4) ◽  
pp. 228-232 ◽  
Author(s):  
Sibyl E. Anderson ◽  
Bruce D. Minsky ◽  
Manjit Bains ◽  
David P. Kelsen ◽  
David H. Ilson

2006 ◽  
Vol 4 (4) ◽  
pp. 375-382 ◽  
Author(s):  
Prajnan Das ◽  
Norio Fukami ◽  
Jaffer A. Ajani

Gastric and esophageal cancers continue to be a significant health problem. The incidence of proximal gastric and distal esophageal cancers has been increasing, especially in white men. Gastric and esophageal cancers have high rates of locoregional and distant failure, resulting in poor overall survival. Therefore, patients with gastric and esophageal cancer may benefit from combined modality therapy. Adjuvant chemoradiation has been shown to improve survival in gastric and gastroesophageal cancers in a phase III trial. In esophageal cancer, most randomized trials have not shown a survival benefit for preoperative chemotherapy or chemoradiation, although these approaches are widely used. This article reviews the role of staging, surgery, and adjuvant and preoperative therapies in the management of localized gastric and esophageal cancers.


1992 ◽  
Vol 24 (4) ◽  
pp. 633-642 ◽  
Author(s):  
Brian Kavanagh ◽  
Mitchell Anscher ◽  
Kenneth Leopold ◽  
Margaret Deutsch ◽  
Elizabeth Gaydica ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document